Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Schrodinger Inc., 3 years.
Schrodinger Inc.
Director
Denali Therapeutics Inc.
Director
Vertex Pharmaceuticals Incorporated
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2024 | Schrodinger Inc. | Grant or award | +5,000 | — | — |
| May 31, 2024 | Denali Therapeutics Inc. | Grant or award | +5,967 | — | — |
| May 1, 2024 | Vertex Pharmaceuticals Incorporated | Grant or award | +501 | — | — |
| Dec 5, 2023 | Vertex Pharmaceuticals Incorporated | Grant or award | +1,136 | — | — |
| Jun 15, 2023 | Schrodinger Inc. | Grant or award | +6,250 | — | — |
| Jun 1, 2023 | Denali Therapeutics Inc. | Grant or award | +4,216 | — | — |
| May 22, 2023 | Schrodinger Inc. | Option exercise | +14,850 | $11.52 | $171,072 |
| May 22, 2023 | Schrodinger Inc. | Open-market sale | −14,850 | $35.00 | $519,750 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.